RSV

CDC officials are investigating a potential link between two recently approved RSV vaccines and increased reports of Guillain-Barré syndrome in adults over 60.

Federal officials made the revelation in a CDC meeting this week.

Study suggests the virus has the potential to infect beyond the respiratory tract.

A recent research paper found that hospitalization rates were over 80 percent for RSV and only 30 percent ...

Infants are likely to avoid hospitalization thanks to a dose of nirsevimab during their first RSV season, a ...

Studies provide updates on vaccination uptake.

The CDC's new vaccine schedule recommends that infants receive their first RSV vaccine before the age of 6 ...

The head of the CDC said that officials believe RSV levels have peaked in the United States.

The CDC said that cases of respiratory viruses are on the rise across the U.S.

A study found infants under 2 months of age were less likely to experience SARS-CoV-2 infection and less ...

The CDC sent a health alert over a shortage of nirsevimab, used to treat RSV.

The CDC has recommended prioritizing infants at the highest risk for severe RSV owing to the short supply ...

The CDC's advisory committee has recommended the RSV vaccine for women in the late stages of their pregnancies.

The CDC noted that fall and winter are generally a time when viruses that cause respiratory disease tend ...

The Centers for Disease Control and Prevention (CDC) is warning physicians and caregivers about an increase in respiratory syncytial virus ...

U.S. drug regulators have approved a drug aimed at preventing a respiratory disease in babies and toddlers. The ...

The U.S. Centers for Disease Control and Prevention's (CDC) panel of experts voted on Wednesday against recommending the ...

An advisory committee to the Centers for Disease Control and Prevention (CDC) on June 21 voted to recommend ...

A panel of outside advisers to the U.S. Food and Drug Administration (FDA) voted in favor of approving a preventative antibody ...

Parents are advised to look out for signs of breathing problems in young children over winter, with a ...

The Food and Drug Administration (FDA) has approved Pfizer’s vaccine, Abrysvo, which protects adults 60 and older from ...

Advisers to the U.S. Food and Drug Administration (FDA) voiced support on May 18 for Pfizer's maternal RSV ...

The FDA approved the first-ever RSV vaccine for adults aged 60 and over—almost 60 years after the first ...

An experimental vaccine targeting respiratory syncytial virus (RSV) was found to be nearly 82 percent effective for infants when ...

A committee of outside advisers to the U.S. Food and Drug Administration (FDA) recommended a vaccine from GlaxoSmithKline (GSK) ...

A panel of outside advisers to the U.S. Food and Drug Administration (FDA) voted to endorse a vaccine ...

Even though many would like to declare the pandemic over, COVID-19 variants are still mutating and circulating globally. ...